INTRODUCTION
============

The chronic respiratory diseases (CRDs) include asthma, chronic obstructive pulmonary disease (COPD), occupational lung diseases, lung fibrosis, and pulmonary hypertension \[[@B1]\]. The prevalence of patients with CRD is increasing particularly in low-middle income countries \[[@B2][@B3]\]. Their main risk factors are tobacco smoking, indoor and outdoor pollution, occupational risk, vulnerability, and allergens sensitization \[[@B1]\]. Recent studies suggested that indoor allergen sensitization is quickly increasing among several Asian countries \[[@B4]\].

Sensitization to house dust mite is the most frequent allergen among asthmatics in China \[[@B5]\], Thailand \[[@B6]\], Singapore \[[@B7]\], and the North of Vietnam \[[@B8]\]. In the South of Vietnam, we recently reported that, dust mites and cockroaches were the most frequent allergens sensitizers among patients with CRD and that the migration from rural to urban area increased the risk of dust mite sensitization \[[@B9]\]. However, due to the frequent consumption of shrimp, as well as the possible known cross-reactivity between dust mite and shrimp, its sensitization has to be considered in this population.

In view of this epidemic, there is a need to screen sensitization among large population to prevent exposure and, if required, implement desensitization. *In vitro* specific IgE (sIgE) assays are currently available only in a limited number of reference centers and it is a financial burden for low income large population while the cheap and unsophisticated skin prick tests (SPTs) can be widely used in most of the healthcare centers. Though, commercial allergen extracts have been validated for western countries but not in other parts of the World where dust mite and cockroach species could be different on an allergenic point of view. Thus, the aim of this study was to validate the SPT, compared to sIgE, to screen dust mite sensitization among patients with CRD in Southern Vietnam.

MATERIALS AND METHODS
=====================

General design and population selection
---------------------------------------

Outpatients were randomly included at Pham Ngoc Thach (PNT) hospital, the reference center for respiratory diseases in Southern Vietnam. Both active and suspected tuberculosis patients were excluded by routine chest X-ray and microbial sputum analysis. After obtained informed written consent, a lung function test (LFT) was measured \[[@B9]\] while blood sampling and SPT were performed after stopping antihistamines at least 5 days.

The main inclusion criteria were the presence of chronic respiratory symptoms lasting 3 months or more with a significant defect of lung function \[[@B9]\]. After measurement of the LFT before and after bronchodilator, asthma and COPD were defined as recommended by Global Initiative for Asthma and the Global Initiative for Chronic Obstructive Lung Disease guidelines \[[@B10][@B11]\].

The study was approved by the Committee of PNT hospital (CS/PT/13/12) and was registered with ClinicalTrials.gov ([NCT02517983](http://clinicaltrials.gov/ct2/show/NCT02517983)).

Skin prick test
---------------

SPT was performed by pricking the Stallerpoint on the back region with a panel of commercial airborne allergens (Stallergenes, France): *Blomia tropicalis* (Blo t), *Dermatophagoides pteronissinus* (Der p), and cockroach (*Blattella germanica*, Bla g). A SPT was also performed with native fresh shrimp in view of the frequent consumption and the cross-reactivity with dust mite. All tests included a positive (histamine) and a negative control.

Wheals and flares were recorded at 15 minutes after allergen testing. The wheal diameter was measured as the average of the largest wheal diameter and its perpendicular. Although there was a large consensus to define a wheal of 3 mm as positive, in our particular Vietnamese population, a cutoff 4 mm was used because some authors recommended this threshold in presence of CRDs \[[@B12]\], and it was less dependent on the race \[[@B13]\] and/or the type of tested allergen \[[@B14]\]. Patients with a histamine reaction \< 4 mm were excluded.

A patient "sensitized to dust mite" was defined as positive for at least Der p and/or Blo t.

Specific IgE
------------

Specific IgE to native house dust mite (Der p), storage mite (Blo t), German/Oriental/American cockroach and shrimp, were measured by using ImmunoCAP (respectively codes: d1, d201, i6/i207/i206, and f24 from Phadia IDM 1000, Uppsala, Sweden). Based on the calculation of the best sensitivity and specificity in regard of positive SPT (see below), a significant level of sIgE ≥ 0.70 kU~A~/L was considered positive. A concentration of sIgE ≥ 0.35 kU~A~/L was defined as detectable threshold.

A patient with sIgE ≥ 0.70 kU~A~/L for Der p and/or Blo t was defined as sensitization to dust mite.

Statistical analysis
--------------------

IBM SPSS Statistics version 23.0 (IBM Co., Armonk, NY, USA) was used for data analysis. The sensitivity and specificity were calculated to validate SPT in regard to sIgE as the "reference standard." The Mantel -- Haenzsel method and logistic regression were used to test the interaction of the age with the smoking effect, on the SPT response as the predictor of sIgE. The agreement between the SPT and sIgE was analysed by using Kappa statistics. Kappa values \< 0.001 indicate poor agreement: 0.001 to 0.20, slight agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, substantial agreement; and 0.81 to 1.00, almost perfect agreement \[[@B15]\]. The optimal sIgE cutoff level was defined by the Youden index J (sensitivity + specificity -- 1) from receiver operating characteristic (ROC) curve computing by positive SPT and sIgE against Der p (had the maximal sum of sensitivity and specificity). The interest of this ROC curve approach, to establish the clinical useful of in vitro IgE tests was reported previously by Plebani et al. \[[@B16]\]. A *p* value \< 0.05 was considered statistically significant.

RESULTS
=======

The demographic characteristics of the studied population (610 patients with CRD, mean age 54 years) with their positivity to SPT, were shown in [Table 1](#T1){ref-type="table"}. The prevalence of sensitization to Der p, Blo t, Bla g was not different in regard with the sex, while it was more frequent among asthmatics compared to COPD. In both asthmatics and COPD, it was more frequent among \< 10 pack-year (PY) smokers compared to heavy smokers.

###### Demographics and clinical characteristics of the whole population and their specific sensitization

![](apa-8-e39-i001)

  Variable           All              Der p (+)    Blo t (+)       Bla g (+)                      
  ------------------ ---------------- ------------ --------------- --------------- -------------- -----------
  No. of patients    610              109 (17.9)   114 (18.7)      77 (12.6)                      
  Sex                                                                                             
                     Male             489          81 (16.6)       86 (17.6)       59 (12.1)      
                     Female           121          28 (23.1)       28 (23.1)       18 (14.9)      
  Age (yr)           54 ± 13          47 ± 13      50 ± 14         50 ± 14                        
  Smoke habits                        *a*                                                         
                     Nonsmoker        167          46 (27.5)       40 (24.0)       24 (14.4)      
                     Ex-smoker        232          31 (13.4)       37 (15.9)       20 (8.6)       
                     Current smoker   211          32 (15.2)       37 (17.5)       33 (15.6)      
  Cumulative smoke                                                                                
                     \<10 PY          243          69 (28.4)       64 (26.3)       38 (15.6)      
                     ≥10 PY           367          40 (10.9)^\*^   50 (13.6)^\*^   39 (10.6)      
  Diagnosis                                                                                       
                     COPD                                                                         
                                      All          340             45 (13.2)       43 (12.7)      36 (10.6)
                                      \<10 PY      103             24 (23.3)       19 (18.4)      13 (12.6)
                                      ≥10 PY       237             21 (8.9)^∥^     24 (10.1)      23 (9.7)
                     Asthma                                                                       
                                      All          186             42 (22.6)^†^    51 (27.4)^†^   30 (16.1)
                                      \<10 PY      89              30 (33.7)       30 (33.7)      17 (19.1)
                                      ≥10 PY       97              12 (12.4)^‡^    21 (21.6)^§^   13 (13.4)
  Others, all        84               21 (25.0)    20 (23.8)       11 (13.1)                      

Values are presented as number (%) or mean ± standard deviation.

(+), positive skin prick tests for *Dermatophagoides pteronissinus* (Der p), *Blomia tropicalis* (Blo t) or *Blattella germanica* (Bla g); PY, pack-year.

^\*^*p* \< 0.001 comparing smokers \< and ≥ 10 PY. ^†^*p* \< 0.001 comparing COPD and asthmatics. ^‡^*p* \< 0.01 comparing smokers \< and ≥ 10 PY among asthmatics. ^§^*p* \< 0.05 comparing smokers \< and ≥ 10 PY among asthmatics. ^∥^*p* \< 0.01 comparing smokers \< and ≥ 10 PY among COPD. *a*: *p* trend.

Based on SPT, more than 45% patients were sensitized to at least 1 allergen ([Fig. 1A](#F1){ref-type="fig"}). The most frequent sensitizers were dust mite allergens (28%) whose Der p 18%, Blo t 19%, and Bla 13%. Less than 5% of the patients were sensitized to shrimp.

![Prevalence of allergen sensitization. (A) Prevalence of positive skin prick test (SPT). (B) Prevalence of positive sIgE. The black bars indicate a cutoff of 0.35 kU~A~/L and the white bares show a cutoff of 0.70 kU~A~/L specific IgE (sIgE). Blo t, *Blomia tropicalis*; Der p, *Dermatophagoides pteronyssinus*; Bla g, *Blattella germanica*; Bla a, *Blattella americana*; Bla o, *Blattella orientalis*.](apa-8-e39-g001){#F1}

The ROC curve was computed by positive SPT and sIgE against Der p. A 76% sensitivity and 76% specificity (1-specificity = 0.24), the Youden index J point had the maximal sum of sensitivity and specificity corresponding to the optimal sIgE cutoff level of 0.70 kU~A~/L. This level was defined as "significant" sIgE in regard with the threshold of the SPT reactivity.

The prevalence of positive sIgE to allergens was displayed in [Fig. 1B](#F1){ref-type="fig"} for 2 different levels defined as "detectable" (≥0.35 kU~A~/L) or "significant" (≥0.70 kU~A~/L). Among the 610 patients, 291 (48%) were significantly sensitized to 1 dust mite allergen (Der p and/or Blo t). Among the mite sensitized patients, 187 (64%) were positive to both allergens, while 87 (30%) and 17 (6%) were monosensitized to Blo t and Der p, respectively.

[Table 2](#T2){ref-type="table"} shows the sensitivity and specificity of SPT to predict positive sIgE (at concentrations of ≥0.35 or ≥0.7 kU~A~/L). For the whole population, the specificity was \>90% for all allergens while the sensitivity was \<50%. The SPT for Blo t and Der p had a sensitivity of only 34% and 41%, while the sensitivity for Bla g was less than 30%; the specificity was more than 92%. Therefore a positive SPT can only detect approximately 30% to 40% of sensitized patients to cockroach or mites and a positive SPT was rarely observed among nonsensitized patients.

###### SPT as predictors of specific IgE
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  sIgE                      No.               Sensitivity (%)   Specificity (%)   Kappa^\*^   *p* value   Sensitivity (%)   Specificity (%)   Kappa^\*^   *p* value   
  ------------------------- ----------------- ----------------- ----------------- ----------- ----------- ----------------- ----------------- ----------- ----------- ---------
  Blo t, all                610               27                93                0.18        \<0.001     34                94                0.29        \<0.001     
  Der p, all                610               33                94                0.29        \<0.001     41                94                0.39        \<0.001     
  German cockroach, all     610               20                93                0.14        \<0.001     24                93                0.20        \<0.001     
  Oriental cockroach, all   608               22                92                0.17        \<0.001     30                92                0.25        \<0.001     
  American cockroach, all   610               21                93                0.16        \<0.001     28                93                0.24        \<0.001     
  Shrimp, all               519               5                 97                0.02        NS          6                 97                0.04        NS          
  Blo t and/or Der p, all   610               39                87                0.31        \<0.001     46                88                0.35        \<0.001     
  Blo t                                                                                                                                                               
                            Asthma            186               34                86          0.05        \<0.01            38                88          0.24        \<0.001
                            COPD              340               20                95          0.04        \<0.001           26                95          0.25        \<0.001
  Der p                                                                                                                                                               
                            Asthma            186               34                92          0.05        \<0.001           37                91          0.28        \<0.001
                            COPD              340               29                96          0.05        \<0.001           41                95          0.43        \<0.001
  Blo t and/or Der p                                                                                                                                                  
                            Asthma            186               44                80          0.06        \<0.01            48                83          0.27        \<0.001
                            COPD              340               31                90          0.04        \<0.001           40                91          0.33        \<0.001
  Blo t                                                                                                                                                               
                            Smoking \<10 PA   243               39                89          0.05        \<0.001           43                90          0.33        \<0.001
                            Smoking ≥10 PA    367               20                95          0.03        \<0.001           27                96          0.24        \<0.001
  Der p                                                                                                                                                               
                            Smoking \<10 PA   243               47                89          0.06        \<0.001           52                88          0.41        \<0.001
                            Smoking ≥10 PA    367               22                97          0.04        \<0.001           30                97          0.33        \<0.001
  Blo T and/or Der p                                                                                                                                                  
                            Smoking \<10 PA   243               55                79          0.06        \<0.001           61                81          0.42        \<0.001
                            Smoking ≥10 PA    367               28                92          0.04        \<0.001           35                92          0.28        \<0.001

SPT, skin prick test; sIgE, specific IgE; Der p, *Dermatophagoides pteronissinus*; Blo t, *Blomia tropicalis*; Bla g, *Blattella germanica*; NS, nonsignificant; COPD, chronic obstructive pulmonary disease; PY, pack-year.

^\*^Kappa association between positive sIgE and SPT.

Based on Kappa coefficient, the agreement between positive SPT and positive sIgE were statistically significant (*p* \< 0.001). Though, among the allergens with a statistical relationship between SPT and sIgE, the level of agreement ranged from slight to fair.

The sensitivity/specificity of the SPT was similar among asthmatics and COPD. The sensitivity of the SPT to Blo t, Der p and combined Der p/Blo t was higher among \<10 PY smokers; 61% of the patients with a positive SPT to Blo t and/or Der p, had a positive sIgE to at least one of the 2 allergens, compared to 35% among the heavy smokers. One can argue that the age and gender could be confounding factors to explain the smoking effect on the sensitivity of the SPT to detect sIgE. Though, among the \<10 PY smokers, the sensitivity of SPT to Blo t and/or Der p was not age-related (chi-square; *p* = nonsignificant \[NS\]) and there was no association between sex and the prevalence of sensitization to Der p (38 of 120 males compared 27 of 111 females, (chi-square; *p* = NS).

DISCUSSION
==========

In southern Vietnam, Blo t and Der p were frequent sensitizers in patients with CRD. Compared to SPT, sIgE was twice frequently positive to most of allergens. A positive SPT to Der p and/or Blo t extracts was a significant predictor for a positive sIgE with a sensitivity \> 60% and specificity \> 80%, among non- or light-smokers (i.e., \< 10 PY).

The high prevalence of dust mite sensitization was consistent with previous studies in Vietnam \[[@B8][@B9][@B17]\]. Consistently with our data, a recent study in northern Vietnam reported a prevalence of sensitization by SPT of 23%, 13%, and 13% to Blo t, Der p, and cockroach, respectively, while sensitization was not associated with asthma \[[@B8]\].

Among the patients with positive sIgE, the SPT detected only 41% of *Dermatophagoides* and 34% of *Blomia* sensitized patients, respectively. There are several explanations for this discrepancy between SPT and sIgE. The allergen commercial extracts used for SPT, contains mainly Der p1 and Der p2, while in Vietnam the dust mite allergic patients could be sensitized to other allergens, such as Der p5 and/or Der p23. These lasts have been recently reported as frequent or major allergens in tropical countries such as Gabon \[[@B18]\] and Thailand \[[@B19]\]. Blo t5 is a major allergen of *Blomia* and has some homologies of Der p5. Since more than 64% of our mite sensitized patients cross-reacted to both dust mite and *Blomia*, Der p5 could also be a significant allergen in our population.

An analysis of commercial European extracts of dust mite indicated that certain natural Der p extracts lack important allergens, on one side, the extracts showed a considerable variability in allergen composition and content as well as in allergenic activity in SPT, on the other side \[[@B20]\]. We used extracts from Stallergenes that were characterized by high concentration of Der p1 and less Der p2 (ratio Der p1/Der p2 = 2.4) while Der p5, Der p10, Der p21, and Der p7 were absent. The lack of these last allergens in the extract from Stallergenes could explain the low frequency of positive SPT to dust mite compared with sIgE against Der p.

The positive sIgE to German or Oriental or American cockroach was more frequent compared to SPT, suggesting that the commercial extract for SPT did not contain all the relevant allergenic components and/or among some patients and/or that positive sIgE were due to sensitization to Cross-reactive Carbohydrate Determinant (CCD). Similarly, the inconsistence between positive SPT (\<4%) and sIgE (26%) to shrimp could be also explained by a sensitization to CCD. A high frequency of patients with IgE for shrimp and negative skin test was also consistent with the epidemiological data characterized by a low frequency of clinical allergy in several Asian countries (\<1% in China, Thailand) \[[@B21]\] compared to the rapid increasing prevalence of dust mite allergies.

The agreement between the sIgE level and SPT was statistically significant among airborne allergens, but the relation was defined as slight or fair. This result was consistent with a recent European study that showed a moderate agreement between both tests to HDM allergen. However, the SPT was more specific for the diagnosis of asthma \[[@B22]\]. One Brazilian study also showed the agreement, although weak, between SPT to Blo t with its sIgE level \[[@B23]\]. The good agreement between SPT and sIgE against cockroach was concluded in a Thai research on allergic respiratory volunteers \[[@B24]\]. A recent study in Korea also concluded a discrepancy between SPT and sIgE to diagnose allergic sensitization among inhalant allergens and this discrepancy was related to the age \[[@B25]\]. One can argue that our population was a mixture of diagnosis. Though the sensitivity/specificity of SPT was similar among asthmatics and COPD, while it was mainly associated with the smoking habits of the patients. Our current data showed that the sensitivity was not related to age, among the group of \<10 PY smokers, suggesting that age was not confounding with "smoking history" on the level of sensitivity of SPT.

One limitation of the study was the 4-mm threshold of positive SPT instead of 3 mm; we cannot exclude a certain loss of sensitivity to screen the sensitized patients. Therefore the conclusions of this study were limited to the Vietnamese population based on the used criteria of sensitization.

We concluded that, based on the present data, SPT to dust mites allergens can be recommended as a first line approach to detect a sensitization among CRD population. With the cost effectiveness and availability of SPT in Vietnam, this method could be extended in the healthcare center in Vietnam.
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